(Total Views: 151)
 Posted On: 09/11/2025 9:20:05 PM 
  
		  		    Post#  of 88		    
			
		      
  
	MM120 Effective as a Single Dose for Generalized Anxiety Disorder: Phase 2b Results | HCP Live  
 
Investigator Maurizio Fava, MD, chair of Mass General Brigham, discusses how MindMed’s MM120 (lysergide D-tartrate, LSD) at 100 μg signficantly reduces anxiety in adults with generalized anxiety disorder (GAD).
 
https://www.hcplive.com/shorts/mm120-effectiv...2b-results
 
Mass General was one of the first providers in the US who offered IV ketamine for depressed people. I predict that will be one of the first adopters of this treatment as well
 	
 
Investigator Maurizio Fava, MD, chair of Mass General Brigham, discusses how MindMed’s MM120 (lysergide D-tartrate, LSD) at 100 μg signficantly reduces anxiety in adults with generalized anxiety disorder (GAD).
https://www.hcplive.com/shorts/mm120-effectiv...2b-results
Mass General was one of the first providers in the US who offered IV ketamine for depressed people. I predict that will be one of the first adopters of this treatment as well
 (0)
(0) (0)
(0) 
      			












